465 related articles for article (PubMed ID: 28420350)
1. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
Sun J; Liu L; Shen J; Chen P; Lu H
BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
[TBL] [Abstract][Full Text] [Related]
2. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
3. [An analysis of factors associated with timeliness of antiretroviral therapy initiation among newly diagnosed HIV/AIDS from 2010 to 2014 in China].
Tang HL; Xu J; Han J; Li J; Mao YR
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):711-717. PubMed ID: 28763920
[No Abstract] [Full Text] [Related]
4. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
Kiertiburanakul S; Boettiger D; Lee MP; Omar SF; Tanuma J; Ng OT; Durier N; Phanuphak P; Ditangco R; Chaiwarith R; Kantipong P; Lee CK; Mustafa M; Saphonn V; Ratanasuwan W; Merati TP; Kumarasamy N; Wong WW; Zhang F; Pham TT; Pujari S; Choi JY; Yunihastuti E; Sungkanuparph S; ;
J Int AIDS Soc; 2014; 17(1):18804. PubMed ID: 24598459
[TBL] [Abstract][Full Text] [Related]
5. The risk factors for suboptimal CD4 recovery in HIV infected population: an observational and retrospective study in Shanghai, China.
Zhang F; Sun M; Sun J; Guan L; Wang J; Lu H
Biosci Trends; 2015 Oct; 9(5):335-41. PubMed ID: 26559026
[TBL] [Abstract][Full Text] [Related]
6. Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.
Shen Y; Wang J; Qi T; Wang Z; Lu H
Int J STD AIDS; 2014 Jun; 25(7):504-10. PubMed ID: 24327726
[TBL] [Abstract][Full Text] [Related]
7. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.
Cescon A; Patterson S; Davey C; Ding E; Raboud JM; Chan K; Loutfy MR; Cooper C; Burchell AN; Palmer AK; Tsoukas C; Machouf N; Klein MB; Rourke SB; Rachlis A; Hogg RS; Montaner JS;
J Int AIDS Soc; 2015; 18(1):20024. PubMed ID: 26443752
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
[TBL] [Abstract][Full Text] [Related]
9. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
[TBL] [Abstract][Full Text] [Related]
10. [Proportion and related influencing factors of HIV-infected individuals that rejecting the antiretroviral therapy among all the HIV infections, Dehong prefecture, Yunnan province].
Yao S; Ye R; Yang Y; Xiang L; Wang J; Du B; Han W; Nie Y; Yang Z; Li W; He N; Duan S
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Dec; 35(12):1324-8. PubMed ID: 25623447
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.
Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ
BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the determinants and changes related to the natural CD4(+) T cell counts among antiretroviral treatment-naive HIV/AIDS patients in Dehong prefecture, Yunnan province].
Ye RH; Duan S; Xiang LF; Yang YC; Yang ZJ; Han WX; Cao DD; Yang JH; Li WM; Yang J; Wang JB; Gao J; Gong YR; Yang SJ; Zhu P; He N
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):882-7. PubMed ID: 22340875
[TBL] [Abstract][Full Text] [Related]
13. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
[TBL] [Abstract][Full Text] [Related]
14. Demographic and clinical factors correlated with clinical outcomes among people with HIV treated by antiretroviral therapy: a retrospective cohort study.
Li Y; Liu H; Zhang S; Zhang Y; Wang H; Zhang H; Li X
BMC Infect Dis; 2024 May; 24(1):514. PubMed ID: 38778273
[TBL] [Abstract][Full Text] [Related]
15. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
Wolbers M; Bucher HC; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M;
HIV Med; 2008 Jul; 9(6):397-405. PubMed ID: 18410354
[TBL] [Abstract][Full Text] [Related]
16. "Late for testing, early for antiretroviral therapy, less likely to die": results from a large HIV cohort study in China, 2006-2014.
Tang H; Mao Y; Tang W; Han J; Xu J; Li J
BMC Infect Dis; 2018 Jun; 18(1):272. PubMed ID: 29895275
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
[TBL] [Abstract][Full Text] [Related]
18. ART initiation in an outpatient treatment center in Dakar, Senegal: A retrospective cohort analysis (1998-2015).
Ngom NF; Faye MA; Ndiaye K; Thiam A; Ndour CT; Etard JF; Sow PS; Seydi M; Delaporte E; Cournil A
PLoS One; 2018; 13(9):e0202984. PubMed ID: 30231075
[TBL] [Abstract][Full Text] [Related]
19. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
[TBL] [Abstract][Full Text] [Related]
20. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
